Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug.
about
Polymersome-based drug-delivery strategies for cancer therapeuticsPolymeric nanoparticles for targeted treatment in oncology: current insightsEfficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in ratsCodelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumorIn Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) PeptideEngineering of the E. coli outer membrane protein FhuA to overcome the hydrophobic mismatch in thick polymeric membranesPolymersomes: a new multi-functional tool for cancer diagnosis and therapy.Characterization of restricted diffusion in uni- and multi-lamellar vesicles using short distance iMQCsPorous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents.Flash nanoprecipitation: particle structure and stability.Enzymatically triggered rupture of polymersomes.Endocytosis and intracellular trafficking properties of transferrin-conjugated block copolypeptide vesicles.Biodegradable Nano-aggregates of Star-Shaped 8-arm PEG-PLLA Block Co-polymers for Encapsulation of Water-Soluble Macromolecules.Platinum covalent shell cross-linked micelles designed to deliver doxorubicin for synergistic combination cancer therapyLarge scale production of vesicles by hollow fiber extrusion: a novel method for generating polymersome encapsulated hemoglobin dispersions.Asymmetrical Polymer Vesicles for Drug delivery and Other ApplicationsPolymersomes as an effective drug delivery system for glioma--a review.Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.A strategy in the design of micellar shape for cancer therapy.Polymer micro- and nanocapsules as biological carriers with multifunctional properties.Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapyPolymersomes containing quantum dots for cellular imagingIntracellular fates of cell-penetrating block copolypeptide vesicles.From stealthy polymersomes and filomicelles to "self" Peptide-nanoparticles for cancer therapyImproved tumor targeting of polymer-based nanovesicles using polymer-lipid blendsFactors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug releaseA simple method for the synthesis of porous polymeric vesicles and their application as MR contrast agentsHydrodynamic interactions of deformable polymeric nanocarriers and the effect of crosslinkingSynthesis and self-assembly of biodegradable polyethylene glycol-poly (lactic acid) diblock copolymers as polymersomes for preparation of sustained release system of doxorubicinDual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor.Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma.Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG.Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles.Multifunctional polyelectrolyte multilayer films: combining mechanical resistance, biodegradability, and bioactivityEngineering nanomedicines for improved melanoma therapy: progress and promises.Assessing Therapeutic Potential of Magnetic Mesoporous Nanoassemblies for Chemo-Resistant Tumors.NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS.
P2860
Q28083454-718ADFA0-C30E-40A1-A8DF-F5E32D0C4DB5Q28087243-4B51FE62-3404-4943-B383-74B42896E9A3Q28484539-57942ED0-4634-4964-B460-362CB9E66F35Q28543911-107B2B60-B607-4F9E-AE98-BE4B7BB781ACQ28550452-37827B24-B011-4B9C-9D62-5CD920DFFA09Q30155616-50474240-2E59-4321-9C6E-64618F8ADD25Q30488115-2F07337D-63BB-41CF-BD10-2452EAB67625Q30565398-72631F8F-E6CF-4559-AA32-09C4248BDBF3Q30584790-D61C031D-5CB6-4384-8D0C-8989D19AEB3EQ30668553-06A3BC21-9A1E-4E9A-BF37-15E2DCF8582BQ30831484-4636B91A-2175-46F3-B552-9FE2D2C14232Q33619608-4F8B8AAD-3127-4B17-B59B-5F19D20ECBCBQ33691028-7EC8646C-D77A-4B11-A4D2-65EEC2D65F11Q33713159-FC523D7B-E151-4E67-A9E9-E1E2D2C2C34CQ33762142-53C0B820-E75F-4F18-B586-33C15A2E705DQ33813218-C675D089-CD37-45E6-BE7D-F04F5EBE2818Q34420100-9C3C19AF-AACC-42C8-870D-497B2AE169D5Q34440323-FC39B7F6-2579-46A0-823C-B857967D2B5DQ34489400-834F2174-23FC-4E3F-A051-31F73EE9884BQ35116954-4CA9DFEF-94A9-4AEE-B727-D9D0AFB3EAD5Q35141276-192D9E37-627B-426D-930E-2068710784BBQ35175653-4E0F1696-9CC8-4964-A92E-3B50542ACF6BQ35194084-6E655042-A23B-46DE-B904-BE02D69D0752Q35295381-38E365FB-1331-444B-9D65-4C6824772A8EQ35399928-7767CB58-49E5-42F6-8E5F-A69DA5BC143BQ35759213-2243F2B9-34AB-469D-A8B4-E001CC06AB6CQ35800930-675E3109-D4D1-41D8-B28B-440806436558Q35875141-E5CF589A-C68D-473B-A438-9B956A10B7C8Q35899936-A43E3828-5EB3-447A-BCE2-8881962263D9Q35910398-41E6BC59-8F65-4316-ABE1-21CB48161932Q35918831-7A5AAB38-F976-4243-A7D7-7C68E81D0EE3Q36081720-A911B340-D5B5-44F7-A0B2-9AB7C7C1A734Q36297929-CA938B74-0BD4-4A2A-90F8-9D5BA2E74FAFQ36312850-A6FED25A-E9EA-47F8-9ED3-B9EB1CAD1182Q36662084-E27A4D32-2E93-43D6-82DD-974346991F5DQ36767228-A238746F-8E4F-49DA-9AB8-E6E3ADA7908AQ36874314-A2B6668B-FA8F-45EC-BB32-7D5FB367158DQ36936646-737D587C-EF4B-492F-B3E6-E8017718FBFDQ37112958-59B81C97-34BD-4FB7-B590-D459FDD2C652Q37201160-33934174-9997-47CB-93DF-718C14594858
P2860
Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Biodegradable polymersomes loa ...... roportion to accumulated drug.
@en
type
label
Biodegradable polymersomes loa ...... roportion to accumulated drug.
@en
prefLabel
Biodegradable polymersomes loa ...... roportion to accumulated drug.
@en
P2093
P50
P1476
Biodegradable polymersomes loa ...... roportion to accumulated drug.
@en
P2093
Aaron Brannan
Fariyal Ahmed
Refika I Pakunlu
P304
P356
10.1016/J.JCONREL.2006.07.012
P407
P577
2006-07-20T00:00:00Z